Jones Financial Companies’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Buy |
29,767
+8,828
| +42% | +$419K | ﹤0.01% | 870 |
|
|
2025
Q1 | $775K | Buy |
20,939
+9,678
| +86% | +$358K | ﹤0.01% | 959 |
|
|
2024
Q4 | $443K | Buy |
11,261
+5,022
| +80% | +$198K | ﹤0.01% | 1038 |
|
|
2024
Q3 | $295K | Buy |
6,239
+2,365
| +61% | +$112K | ﹤0.01% | 1005 |
|
|
2024
Q2 | $209K | Buy |
3,874
+2,709
| +233% | +$146K | ﹤0.01% | 822 |
|
|
2024
Q1 | $79.4K | Buy |
+1,165
| New | +$79.4K | ﹤0.01% | 639 |
|